Literature DB >> 26555423

[The value of narrow-band imaging with magnifying endoscopy in diagnosis of early gastric cancer: a meta-analysis].

Wei Huang1, Lei Wang1, Jing Du1, Jian-min Yang1.   

Abstract

OBJECTIVE: To assess the diagnostic value of narrow-band imaging with magnifying endoscopy (NBI-ME) for early gastric cancer (EGC).
METHODS: We searched PubMed, Embase, Web of Science and the Cochrane Library for literature of NBI-ME in diagnosis of EGC, and then performed meta-analysis.
RESULTS: A total of 12 articles involving 2 278 samples from 2 048 patients were included. The overall sensitivity of NBI-ME for diagnosis of EGC was 0.84 [95% CI: 0.80~0.87], specificity was 0.96 (95% CI: 0.95~0.97),and area under the symmetric receiver operator characteristic curve (AUC) was 0.9592. The AUC value of the NBI-ME plus conventional white light endoscopy (C-WLE) subgroup (0.9706) was higher than that of NBI-ME alone (0.8162). The incremental yield of NBI-ME plus C-WLE over C-WLE was significant (IY = 9.4%, P = 0.011), while NBI-ME alone over C-WLE was not significant (IY = 0.8%, P = 0.498).
CONCLUSIONS: The results show that NBI-ME plus C-WLE is an effective and preferable method for diagnosis of EGC; however, NBI-ME alone is not superior to C-WLE.

Entities:  

Mesh:

Year:  2015        PMID: 26555423     DOI: 10.3785/j.issn.1008-9292.2015.07.14

Source DB:  PubMed          Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban        ISSN: 1008-9292


  2 in total

1.  Diagnostic performance of magnifying endoscopy with narrow-band imaging in differentiating neoplastic colorectal polyps from non-neoplastic colorectal polyps: a meta-analysis.

Authors:  Tian-Jiao Guo; Wei Chen; Yao Chen; Jun-Chao Wu; Yi-Ping Wang; Jin-Lin Yang
Journal:  J Gastroenterol       Date:  2018-01-30       Impact factor: 7.527

2.  The value of narrow band imaging in diagnosis of head and neck cancer: a meta-analysis.

Authors:  Hui Zhou; Jing Zhang; Linghong Guo; Ji Nie; Chenjing Zhu; Xuelei Ma
Journal:  Sci Rep       Date:  2018-01-11       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.